No Data
No Data
TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $5
Buy Rating on Humacyte: Long-Term Growth Potential and Symvess Launch Optimism
Top Directors Make Bold Moves With Humacyte Stock Purchases!
Insider Purchase: Director at $HUMA Buys 50,000 Shares
Express News | Humacyte Inc : Piper Sandler Cuts Target Price to $3 From $6
10-K: FY2024 Annual Report